Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma


Sozen H., Ciftci R., Vatansever D., Topuz S., Iyibozkurt A. C., Bozbey H. U., ...More

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, vol.56, no.2, pp.199-206, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 56 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.1111/ajo.12449
  • Journal Name: AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.199-206
  • Keywords: chemotherapy, endometrial carcinosarcoma, radiotherapy, type II endometrial cancer, PAPILLARY SEROUS CARCINOMA, MIXED MULLERIAN TUMORS, UTERINE, UTERUS, OUTCOMES, THERAPY, COHORT
  • Istanbul University Affiliated: Yes

Abstract

AimsThe aim of this study was to describe the impact of postoperative adjuvant treatment modalities and identify risk factors associated with recurrence and survival rates in women diagnosed with early stage type II endometrial cancer and carcinosarcoma.